These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 27325652)
21. Pentamidine is an inhibitor of PRL phosphatases with anticancer activity. Pathak MK; Dhawan D; Lindner DJ; Borden EC; Farver C; Yi T Mol Cancer Ther; 2002 Dec; 1(14):1255-64. PubMed ID: 12516958 [TBL] [Abstract][Full Text] [Related]
22. PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo. Qian F; Li YP; Sheng X; Zhang ZC; Song R; Dong W; Cao SX; Hua ZC; Xu Q Mol Med; 2007; 13(3-4):151-9. PubMed ID: 17592549 [TBL] [Abstract][Full Text] [Related]
23. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466 [TBL] [Abstract][Full Text] [Related]
24. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells. Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018 [TBL] [Abstract][Full Text] [Related]
25. Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver. Hoeger B; Diether M; Ballester PJ; Köhn M Eur J Med Chem; 2014 Dec; 88():89-100. PubMed ID: 25159123 [TBL] [Abstract][Full Text] [Related]
26. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells. Achiwa H; Lazo JS Cancer Res; 2007 Jan; 67(2):643-50. PubMed ID: 17234774 [TBL] [Abstract][Full Text] [Related]
27. A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3). Rivas DR; Dela Cerna MVC; Smith CN; Sampathi S; Patty BG; Lee D; Blackburn JS Sci Rep; 2021 May; 11(1):10302. PubMed ID: 33986418 [TBL] [Abstract][Full Text] [Related]
28. Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity. Han YM; Lee SK; Jeong DG; Ryu SE; Han DC; Kim DK; Kwon BM Bioorg Med Chem Lett; 2012 Jan; 22(1):323-6. PubMed ID: 22137788 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression. Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483 [TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor. Yaguchi S; Fukui Y; Koshimizu I; Yoshimi H; Matsuno T; Gouda H; Hirono S; Yamazaki K; Yamori T J Natl Cancer Inst; 2006 Apr; 98(8):545-56. PubMed ID: 16622124 [TBL] [Abstract][Full Text] [Related]
31. Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3. Abdollahi P; Vandsemb EN; Hjort MA; Misund K; Holien T; Sponaas AM; Rø TB; Slørdahl TS; Børset M Mol Cancer Res; 2017 Jan; 15(1):69-77. PubMed ID: 27698077 [TBL] [Abstract][Full Text] [Related]
32. Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo. Grosskopf S; Eckert C; Arkona C; Radetzki S; Böhm K; Heinemann U; Wolber G; von Kries JP; Birchmeier W; Rademann J ChemMedChem; 2015 May; 10(5):815-26. PubMed ID: 25877780 [TBL] [Abstract][Full Text] [Related]
33. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Fiordalisi JJ; Keller PJ; Cox AD Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma. Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476 [TBL] [Abstract][Full Text] [Related]
35. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
36. PRL3-zumab, a first-in-class humanized antibody for cancer therapy. Thura M; Al-Aidaroos AQO; Yong WP; Kono K; Gupta A; Lin YB; Mimura K; Thiery JP; Goh BC; Tan P; Soo R; Hong CW; Wang L; Lin SJ; Chen E; Rha SY; Chung HC; Li J; Nandi S; Yuen HF; Zhang SD; Guan YK; So J; Zeng Q JCI Insight; 2016 Jun; 1(9):e87607. PubMed ID: 27699276 [TBL] [Abstract][Full Text] [Related]
37. Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis. Bai Y; Zhou HM; Zhang L; Dong Y; Zeng Q; Shou W; Zhang ZY Sci Rep; 2016 Sep; 6():34211. PubMed ID: 27666520 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the protein tyrosine phosphatase PRL from Entamoeba histolytica. Ramírez-Tapia AL; Baylón-Pacheco L; Espíritu-Gordillo P; Rosales-Encina JL Exp Parasitol; 2015 Dec; 159():168-82. PubMed ID: 26431820 [TBL] [Abstract][Full Text] [Related]
39. Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration. Vandsemb EN; Bertilsson H; Abdollahi P; Størkersen Ø; Våtsveen TK; Rye MB; Rø TB; Børset M; Slørdahl TS J Transl Med; 2016 Mar; 14():71. PubMed ID: 26975394 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory activities of anthraquinones from Rubia akane on phosphatase regenerating liver-3. Moon MK; Han YM; Lee YJ; Lee LH; Yang JH; Kwon BM; Kim DK Arch Pharm Res; 2010 Nov; 33(11):1747-51. PubMed ID: 21116777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]